Antonia Dimitrakopoulou‐Strauss

SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors

Clemens Kratochwil, M. Stefanova, Eleni Mavriopoulou et al. · Molecular Imaging and Biology · 2014 · 211 citations

Positron Emission Tomography, Neuro-oncology, Oncologic Imaging +8

Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

Hoda Anwar, Christos Sachpekidis, Julia K. Winkler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2017 · 190 citations

Oncologic Imaging, Suv Changes, Melanoma +6

Clinical Value of [18-F] Fluorodeoxyglucose Positron Emission Tomography Imaging in Soft Tissue Sarcomas

Matthias Schwarzbach, Antonia Dimitrakopoulou‐Strauss, Frank Willeke et al. · Annals of Surgery · 2000 · 187 citations · Full text

Characterization of 68Ga-DOTA-D-Phe1-Tyr3-octreotide kinetics in patients with meningiomas.

Marcus Henze, Antonia Dimitrakopoulou‐Strauss, Stefanie Milker-Zabel et al. · PubMed · 2005 · 163 citations

Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI

Martin T. Freitag, Jan Philipp Radtke, Ali Afshar‐Oromieh et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 161 citations

Positron Emission Tomography, Urology, Surgical Oncology +11